Radionuclide imaging
Showing 1 - 25 of >10,000
Solid Tumor Trial in Beijing (68Ga-DX600 PET/CT)
Completed
- Solid Tumor
- 68Ga-DX600 PET/CT
-
Beijing, Beijing, ChinaEthics Committee of Peking University Cancer Hospital
Jul 18, 2022
Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)
Active, not recruiting
- Breast Cancer
- +11 more
- radionuclide imaging
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 20, 2022
Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)
Recruiting
- Prostatic Neoplasms, Castration-Resistant
- Radionuclide Therapy
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Jun 5, 2023
Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine
Not yet recruiting
- Digestive System Neuroendocrine Tumor G1
- +5 more
- Tumor Debulking
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 23, 2023
Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial
Not yet recruiting
- Malignant Female Reproductive System Neoplasm
- +3 more
- Biopsy
- +7 more
- (no location specified)
Nov 9, 2023
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial
Not yet recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- +5 more
- Interferon Beta-1A
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Biospecimen Collection
- +8 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 27, 2023
Mantle Cell Lymphoma Trial in Duarte (drug, procedure, biological)
Not yet recruiting
- Mantle Cell Lymphoma
- Acalabrutinib
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 20, 2023
Neuroendocrine Tumors, Hyperthyroidism, Thyroid Cancer Trial in London (Nuclear Medicine whole-body, SPECT/CT imaging., PET/CT
Recruiting
- Neuroendocrine Tumors
- +3 more
- Nuclear Medicine whole-body
- +4 more
-
London, United KingdomGuy's and St Thomas Hospitals Foundation Trust
Jan 5, 2022
Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Triple Negative Breast Cancer
- Aldesleukin
- +12 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 9, 2023
Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in
Not yet recruiting
- Metastatic Colorectal Adenocarcinoma
- +5 more
- Bendamustine
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 12, 2023
Ovarian Cancer Trial in Indianapolis, Saint Louis, Houston (radionuclide imaging, indium In 111 folic acid)
Completed
- Ovarian Cancer
- radionuclide imaging
- indium In 111 folic acid
-
Indianapolis, Indiana
- +2 more
Sep 24, 2021
Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8
Not yet recruiting
- Stage II Nasopharyngeal Carcinoma AJCC v8
- +2 more
- Biopsy
- +16 more
- (no location specified)
Oct 7, 2023
Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,
Not yet recruiting
- Prostate Carcinoma
- +3 more
- Bendamustine
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 10, 2023
Prostate Cancer Trial in Glen Burnie, Omaha, Knoxville (PSMA-Targeted [In-111]-Labeled Trillium Compound, PTI-122)
Recruiting
- Prostate Cancer
- PSMA-Targeted [In-111]-Labeled Trillium Compound
- PTI-122
-
Glen Burnie, Maryland
- +2 more
Mar 21, 2023
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,
Not yet recruiting
- Acute Leukemia of Ambiguous Lineage
- +8 more
- Biospecimen Collection
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 22, 2023
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial in United States (Biospecimen
Recruiting
- Recurrent Langerhans Cell Histiocytosis
- Refractory Langerhans Cell Histiocytosis
- Biospecimen Collection
- +8 more
-
Wilmington, Delaware
- +3 more
Apr 28, 2023
Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Locally Advanced Malignant Solid Neoplasm
- Binimetinib
- +22 more
- (no location specified)
Dec 2, 2022
Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial
Not yet recruiting
- Recurrent Biliary Tract Carcinoma
- +13 more
- Binimetinib
- +10 more
- (no location specified)
Nov 8, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (Biospecimen Collection, Chest
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Biospecimen Collection
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 9, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11GBq of 177Lu-EB-PSMA-617, 2.00 GBq of 177Lu-EB-PSMA-617,
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- 1.11GBq of 177Lu-EB-PSMA-617
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
May 6, 2022
Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)
Not yet recruiting
- Acute Myeloid Leukemia
- Myeloid Neoplasm
- Biospecimen Collection
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 5, 2023
Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone
Not yet recruiting
- Acute Myeloid Leukemia With KMT2A Rearrangement
- Acute Myeloid Leukemia With NPM1 Mutation
- Biospecimen Collection
- +7 more
- (no location specified)
Jun 1, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspiration)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Azacitidine
- +10 more
- (no location specified)
Jan 13, 2023